中山外痔手术贵不贵-【中山华都肛肠医院】,gUfTOBOs,中山津南区哪个医院做痔疮好,内外痔选中山肛泰医院,中山便秘还便血是怎么回事,中山屁眼出血不痛,中山拉屎干燥出血怎么回事,中山治疗痔疮的最好办法

BEIJING, Dec. 20 (Xinhua) -- A senior Chinese official called for a higher level of requirements for promoting cultural and ethical progress at a national conference Tuesday.Li Changchun, a member of the Standing Committee of the Political Bureau of the Communist Party of China (CPC) Central Committee urged for efforts to "provide firm ideological assurance, powerful spiritual drive, effective media support and sound cultural conditions for achieving the great goal of building an overall prosperous society."Li, also director of the Central Spiritual Civilization Development Steering Commission, made the remark while addressing the National Award-issuing Conference on the Work of Cultural and Ethical Progress.Li Changchun (1st L), a Standing Committee member of the Political Bureau of the Communist Party of China (CPC) Central Committee and director of the Central Spiritual Civilization Development Steering Commission, presents the awards to the advanced collectives and individuals during the National Award-issuing Conference on the Work of Cultural and Ethical Progress held in Beijing, capital of China, Dec. 20, 2011. Li attended the conference on Tuesday and gave a speech.In his speech, Li extended his gratefulness to everyone engaged in cultural and ethical work at all levels, as well as to people from all walks of life for their active participation in, and support of, the work.Currently, publicizing the Party's new plenary session should be the primary task in cultural and ethical work, Li said."Cultural and ethical progress is a major component of the socialist cause with China's own characteristics," he said, emphasizing that substantial efforts must be made to strengthen Party leadership on the work.The meeting was presided over by Liu Yunshan, a member of the Political Bureau of the CPC Central Committee and deputy-director of the Central Spiritual Civilization Development Steering Commission.In an address at the gathering, he called for greater efforts in publicizing the models of cultural and ethical progress, so as to "enhance the level of civilization of the society as a whole."A total of 27 cities and municipal districts, 899 villages and small towns, and 1,794 institutions and enterprises were awarded for their marked achievements in cultural and ethical progress, and 23 cities and municipal districts that had been previously awarded were allowed to keep their honorary titles.
BANGKOK, Nov. 4 (Xinhua) -- Hundreds of Bangkok residents gathered in the city centre on Thursday, making ten thousand micro-organism balls to help clean the polluted water in flooded areas.Organized by local volunteer groups, the activity aimed to make 10,000 Effective Micro-organism balls (EM Ball), which are proven to be efficient in cleaning contaminated floodwater.According to Danal Chanchaochai, the organizer of the event, people in flooded areas were facing critical conditions as germs may spread in polluted water and threat their health. Mainly consist of soil, rice bran and micro-organisms, a tennis-sized EM Ball is capable to clean up 10 liter of water and can last for as long as one month, which making it a perfect water sanitizer.Another main objective of the event was to educate citizens on the simple steps of making EM Balls, in case of more flood in the city, he said.The organization had generated buzz on social media sites like facebook and twitter, calling everyone to help.Held at Amarin Plaza, one shopping mall at city centre, the activity attracted groups of volunteers, including office workers, local students and even foreign visitors.Volunteers were lining up to get the raw materials from the collection point and gave back completed EM Balls to the distribution centre in boxes. Residents needed to present their identity cards in order to retrieve the donated water cleaners.Volunteer Kulawan Ayura Chai said that, although her house hadn' t been affected by water yet, she understood the difficult situation faced by the victims and felt responsible to help.Lasted for three days from Thursday to Saturday, the activity aimed to make 100,000 EM Balls, adding to the 30,000 balls made earlier, to distribute to the flood victims in Bangkok and other regions in Thailand.

WASHINGTON, Nov. 11 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved HEMACORD, the first licensed hematopoietic progenitor cells-cord cell therapy.HEMACORD is indicated for use in hematopoietic stem cell transplantation procedures in patients with disorders affecting the blood forming system. For example, cord blood transplants have been used to treat patients with certain blood cancers and some inherited metabolic and immune system disorders."The use of cord blood hematopoietic progenitor cell therapy offers potentially life-saving treatment options for patients with these types of disorders," said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement.HEMACORD contains hematopoietic progenitor cells (HPCs) from human cord blood. Cord blood is one of three sources of HPCs used in transplants. The other two are bone marrow and peripheral blood. Once these HPCs are infused into patients, the cells migrate to the bone marrow where they divide and mature. When the mature cells move into the bloodstream they can partially or fully restore the number and function of many blood cells, including immune function.
BEIJING, Sept. 30 (Xinhuanet) -- Tobacco companies concealed the knowledge of radioactive substance in cigarettes from public for over four decades, a new study revealed.The revelation was made by a research team from the University of California, Los Angeles, published on Thursday in the online edition of the U.S. medical journal Nicotine and Tobacco Research.The researchers analyzed 27 timeworn documents and discovered that tobacco companies had knew the existence of polonium-210, a hazardous radioactive substance, in the tobacco since 1959.The companies studied polonium-210 throughout the 1960s, and concealed their findings about the carcinogenic potential of the radioactive substance.Hrayr Karagueuzian, the study's lead author, said the tobacco companies' deception surprised him.According to the revelation, the companies had knew the "cancerous growths" in the lungs of smokers, and even calculated how much radiation a regular smoker would inhale over 20 years.Karagueuzian and his team conducted again the study recorded in the tobacco documents and found that the radiation in cigarettes would cause up to 138 deaths for every 1,000 smokers over a period of 25 years.However, tobacco manufacturer denied that they had concealed the facts from the public.David Sutton, spokesman of Philip Morris, the largest U.S. tobacco company, said the polonium-210 was a "naturally occurring element in the air" and had been widely discussed by the public health community for years.
WASHINGTON, Dec. 21 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Wednesday approved Isentress for the treatment of HIV-1 infection for children and adolescents.The drug is part of a class of medications called HIV integrase strand transfer inhibitors that works by slowing the spread of HIV in the body. It was first approved for use in adult patients in October 2007, under FDA's accelerated approval program."Many young children and adolescents are living with HIV and this approval provides an important additional option for their treatment," said Edward Cox, director of the Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research.Isentress is a pill that can be taken twice daily, with or without food. The pill is also available in a chewable form. As the two tablet formulations are not interchangeable, the chewable form is only approved for use in children ages 2 to 11.A single, multi-center clinical trial of 96 children and adolescents aged 2-18 years with HIV-1 infection evaluated the safety and effectiveness of Isentress. These patients previously received treatment for HIV-1 infection. After 24 weeks of treatment with Isentress, 53 percent of these patients had an undetectable amount of HIV in their blood.According to the FDA, the most commonly reported severe, treatment-related side effects in patients taking Isentress include trouble sleeping and headache. The frequency of these side effects is similar for children and adults. One pediatric patient reported severe treatment-related insomnia, while another pediatric patient experienced a drug-related skin rash.
来源:资阳报